Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Laparoscopic Colectomy

NCT05764525 is registered in ClinicalTrials.gov with Vivozon Pharmaceutical Inc. as lead sponsor.

NCT NCT05764525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05764525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Laparoscopic Colectomy
Lead sponsor
Vivozon Pharmaceutical Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 19, 2021
Completion date
November 22, 2022
Enrollment
285 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, pain, postoperative